Pegasus Partners’s Bristol-Myers Squibb BMY Stock Holding History

Pegasus Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,350	Closed	-$214K	–	135
2023 Q2	$214K	Hold	3,350	–	–	0.03%	113
2023 Q1	$232K	Hold	3,350	–	–	0.04%	112
2022 Q4	$241K	Hold	3,350	–	–	0.04%	108
2022 Q3	$238K	Sell	3,350 -302	-8%	-$21.9K	0.05%	106
2022 Q2	$281K	Sell	3,652 -98	-3%	-$7.46K	0.06%	99
2022 Q1	$274K	Buy	+3,750	New	+$252K	0.05%	106
2021 Q3	–	Sell	-3,250	Closed	-$217K	–	164
2021 Q2	$217K	Hold	3,250	–	–	0.04%	155
2021 Q1	$205K	Hold	3,250	–	–	0.04%	158
2020 Q4	$202K	Buy	+3,250	New	+$200K	0.05%	146
2020 Q1	–	Sell	-7,826	Closed	-$502K	–	132
2019 Q4	$502K	Buy	+7,826	New	+$448K	0.15%	111
2018 Q4	–	Sell	-3,972	Closed	-$247K	–	136
2018 Q3	$247K	Hold	3,972	–	–	0.05%	129
2018 Q2	$220K	Sell	3,972 -505	-11%	-$27.3K	0.05%	139
2018 Q1	$283K	Buy	4,477 +172	+4%	+$11.1K	0.06%	130
2017 Q4	$264K	Hold	4,305	–	–	0.05%	148
2017 Q3	$274K	Buy	+4,305	New	+$251K	0.06%	144
2016 Q3	–	Sell	-2,900	Closed	-$213K	–	113
2016 Q2	$213K	Buy	+2,900	New	+$205K	0.11%	107
2016 Q1	–	Sell	-3,900	Closed	-$268K	–	113
2015 Q4	$268K	Buy	+3,900	New	+$258K	0.13%	78

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pegasus Partners's BMY Position: Q3 2023 in Review

Pegasus Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,350 shares — an estimated $214K sold.

Pegasus Partners first reported a position in BMY in Q4 2015 and held it in 17 quarters. The position peaked at $502K in Q4 2019. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Pegasus Partners reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Pegasus Partners sold 3,350 Bristol-Myers Squibb shares in Q3 2023, an estimated $214K.
Pegasus Partners first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 17 quarters.
Pegasus Partners's Bristol-Myers Squibb position peaked at $502K in Q4 2019.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Pegasus Partners's 13F filing for Q3 2023, filed 13 Nov 2023.